Wait—Is Mouth Taping the Key to Better Sleep? What Experts Say
Breathing through your nose also releases nitric oxide. Nitric oxide is a vasodilator, which means it helps widen your blood ...
thecardiologyadvisor.com3h
Positive Airway Pressure Use Tied to Lower Cardiovascular Events
Positive airway pressure (PAP) utilization is associated with lower all-cause mortality and MACE incidence in older adults with OSA.
Monthly Prescribing Reference1d
FDA Clears Apple’s Sleep Apnea Notification Feature
The over-the-counter medical application is intended for individuals aged 18 years and older who have not been previously diagnosed with sleep apnea.
FDA Approval Sends Shares of this Healthcare Company Higher
What a session it was for a certain Colorado-based %Healthcare company after it was announced that it received the US Food ...
bovnews1d
Vivos Therapeutics (VVOS) Surges Following Landmark FDA Approval
Vivos Therapeutics is a pioneering medical device and technology company focused on addressing sleep-related breathing disorders (SRBDs), particularly obstructive sleep apnea (OSA). Their flagship ...
ResMed slips as Wolfe downgrades on GLP-1 threat from Lilly
ResMed (RMD) stock falls as Wolfe downgrades due to potential label expansion for Eli Lilly's (LLY) tirzepatide in ...
Vivos surges on FDA nod for pediatric sleep apnea device
Vivos Therapeutics (VVOS) stock gains as company receives FDA clearance for its DNA appliance to treat obstructive sleep ...
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Awarded First-Ever FDA Clearance for Pediatric Treatment of Sleep Apnea, Snoring
Vivos Therapeutics (NASDAQ: VVOS), a leading medical-device and technology company specializing in the development and commercialization of highly effective proprietary treatments for sleep-related ...
Vivos Therapeutics Says It Is Poised To Disrupt Pediatric Sleep Apnea Market, Secures FDA Approval For DNA Appliance To Treat Snoring In Children
The FDA has granted 510(k) clearance to Vivos Therapeutics' DNA oral appliance for treating moderate to severe obstructive ...
MarketWatch2d
Vivos Therapeutics Shares Rally on FDA Clearance for Pediatric Sleep Apnea Treatment
said this is believed to be the first ever FDA clearance to treat moderate to severe obstructive sleep apnea and snoring in children. The 510(k) clearance allows medical devices to enter the U.S.